유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).

유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 ja 5. 1 erinevate kombinatsioonide kohta kättesaadavate andmete osas).

에스토니아 - 에스토니아어 - Ravimiamet

b. braun melsungen ag - joodpovidoon - nahalahus - 75mg 1g 100ml 1tk; 75mg 1g 1000ml 1tk

에스토니아 - 에스토니아어 - Ravimiamet

b. braun melsungen ag - joodpovidoon - salv - 100mg 1g 20g 1tk; 100mg 1g 100g 1tk

유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

novartis europharm limited  - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - diabeetis kasutatavad ravimid - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

유럽 연합 - 에스토니아어 - EMA (European Medicines Agency)

novartis europharm limited - vildagliptin, metformiin vesinikkloriid - suhkurtõbi, tüüp 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

에스토니아 - 에스토니아어 - Ravimiamet

b. braun melsungen ag - ibuprofeen - infusioonilahus - 6mg 1ml 100ml 20tk; 6mg 1ml 100ml 10tk

에스토니아 - 에스토니아어 - Ravimiamet

b. braun melsungen ag - elektrolüüdid - infusioonilahus - 1000ml 10tk; 500ml 10tk

에스토니아 - 에스토니아어 - Ravimiamet

b. braun melsungen ag - ibuprofeen - infusioonilahus - 4mg 1ml 100ml 20tk; 4mg 1ml 100ml 10tk

에스토니아 - 에스토니아어 - Ravimiamet

b. braun melsungen ag - paratsetamool - infusioonilahus - 10mg 1ml 50ml 10tk; 10mg 1ml 100ml 10tk; 10mg 1ml 10ml 20tk